Protalix BioTherapeutics Inc (PLX)
1.67
-0.02
(-1.18%)
USD |
NYAM |
Nov 21, 16:00
1.65
-0.02
(-1.20%)
After-Hours: 20:00
Protalix BioTherapeutics Market Cap: 122.97M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 124.44M |
| November 19, 2024 | 120.02M |
| November 18, 2024 | 122.23M |
| November 15, 2024 | 103.09M |
| November 14, 2024 | 103.82M |
| November 13, 2024 | 91.31M |
| November 12, 2024 | 97.20M |
| November 11, 2024 | 88.36M |
| November 08, 2024 | 85.42M |
| November 07, 2024 | 85.42M |
| November 06, 2024 | 89.83M |
| November 05, 2024 | 95.72M |
| November 04, 2024 | 94.25M |
| November 01, 2024 | 92.04M |
| October 31, 2024 | 86.15M |
| October 30, 2024 | 86.15M |
| October 29, 2024 | 86.15M |
| October 28, 2024 | 83.21M |
| October 25, 2024 | 79.52M |
| October 24, 2024 | 75.84M |
| October 23, 2024 | 75.11M |
| October 22, 2024 | 78.05M |
| October 21, 2024 | 78.05M |
| October 18, 2024 | 80.26M |
| October 17, 2024 | 80.26M |
| Date | Value |
|---|---|
| October 16, 2024 | 80.26M |
| October 15, 2024 | 79.52M |
| October 14, 2024 | 78.05M |
| October 11, 2024 | 79.52M |
| October 10, 2024 | 73.63M |
| October 09, 2024 | 74.37M |
| October 08, 2024 | 75.11M |
| October 07, 2024 | 75.11M |
| October 04, 2024 | 79.52M |
| October 03, 2024 | 74.37M |
| October 02, 2024 | 75.11M |
| October 01, 2024 | 77.32M |
| September 30, 2024 | 75.11M |
| September 27, 2024 | 77.22M |
| September 26, 2024 | 78.69M |
| September 25, 2024 | 80.16M |
| September 24, 2024 | 79.43M |
| September 23, 2024 | 82.37M |
| September 20, 2024 | 80.90M |
| September 19, 2024 | 84.57M |
| September 18, 2024 | 80.16M |
| September 17, 2024 | 80.90M |
| September 16, 2024 | 80.16M |
| September 13, 2024 | 77.22M |
| September 12, 2024 | 77.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
31.16M
Minimum
Mar 16 2020
282.28M
Maximum
Apr 23 2021
95.27M
Average
87.14M
Median
Jan 13 2023
Market Cap Benchmarks
| Accuray Inc | 190.57M |
| Aethlon Medical Inc | 5.361M |
| AIM ImmunoTech Inc | 13.47M |
| Perspective Therapeutics Inc | 202.09M |
| Armata Pharmaceuticals Inc | 75.98M |
Market Cap Related Metrics
| PS Ratio | 2.872 |
| Price to Book Value | 3.791 |
| Price to Free Cash Flow | 18.29 |
| Price | 1.67 |
| Earnings Yield | -9.58% |